An underground market for unapproved weight-loss drugs is propelled by social media fitness personalities and vendors on messaging platforms, according to new investigations.
Experimental Treatment Acquiring Popularity Online
The experimental drug, which is still in clinical trials, is being promoted by online personalities for its alleged weight-reducing properties. Followers are urged to contact these accounts privately for supplier links, while also receiving promotional offers.
Thriving Commerce on Social Networks
Separately, a robust market exists on messaging services, where communities with thousands of participants share comparison photos, injection guides and claims of next-day UK delivery. Vendors promote the drug there before redirecting buyers to WhatsApp for transactions.
Understanding The Experimental Drug
This medication is an experimental injectable created by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could assist individuals lose up to 25% of their total weight. Referred to as the “triple G”, the drug is being hailed online as the successor to Ozempic.
Healthcare Experts Express Concerns
However, doctors and pharmacists have cautions that the distribution of what remains an unapproved drug in the UK is worrisome and could lead to individuals administering substances of uncertain source.
Some professionals stated the demand for retatrutide could be linked to the increasing price of approved weight loss products such as Mounjaro.
Legal Position and Enforcement
Selling the unapproved drug on TikTok or messaging apps is prohibited in the UK, as it is an unapproved medication that must not be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.
Some content creators try to sidestep the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and supply can still breach medicines, marketing, and customer laws, potentially leading to fines, prosecution or prison.
Service Response and Content Removal
According to TikTok, the platform has taken down violative material and prohibited related hashtags and query recommendations. The company said it was dedicated to maintaining the service secure and allocating resources in strengthening compliance measures.
Digital Marketplace Operations
Research also found communities with up to 9,000 members selling the experimental drug using the platform's built-in discovery tool, which operates like a public directory. Entering “retatrutide” instantly brings up channels with numerous of members, populated with images of weight loss, positive testimonials and step-by-step instructions for mixing or administering at home.
After moments of entering one community, a vendor posted contact information, where most transactions occur. The vendor provided an instruction manual and guaranteed shipping within 48 hours. When questioned whether the substance was genuine, one vendor responded: “You can’t be sure.” Another provided a photo of a supposed testing documentation. None inquired about weight, health issues or past usage.
Product Information and Pricing
Inside these communities, posts display black plastic packages with Royal Mail stickers, stating to include new batches. One communication read: “It took eight of us to load them this morning.”
Customers can choose between powder vials, mixed at home with sterile water, or ready-to-use injectors typically priced at £160 for 20mg. When asked how long a pen should last, sellers give conflicting responses ranging from a few weeks to “depends on your body”.
Platform Moderation and Safety Actions
A spokesperson for Telegram said it actively moderated dangerous material on its service including material that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Warnings
“People are injecting materials they can’t verify. Even if the science behind retatrutide is valid, these online products may not include what they advertise,” said a pharmacy expert, the head of pharmacy at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor linked the increase in interest to current price rises for authorized weight-loss drugs such as Mounjaro. “With prices increasing, patients are using online platforms. But fake injections are extremely risky. You can’t be certain what’s contained or whether the environment they were made in was sterile,” she explained.
Her team has already seen patients harmed by personal administration from unconfirmed sources. “We recognize the frustration, but purchasing from messaging apps or communication platforms is taking chances with your well-being,” said the doctor. “These substances could be contaminated or incorrectly dosed.”
Manufacturer Position
A representative from the pharmaceutical company said the substance was in phase 3 clinical trials and had not been evaluated or authorized by any regulatory agency globally. “Consequently at this time no one can sell [it] for personal consumption,” they explained, adding that any item “falsely representing itself as a company investigational product not yet approved … may expose patients to possibly significant health risks”.
